203 related articles for article (PubMed ID: 17959643)
1. Increased activation of p38 MAPK in COPD.
Renda T; Baraldo S; Pelaia G; Bazzan E; Turato G; Papi A; Maestrelli P; Maselli R; Vatrella A; Fabbri LM; Zuin R; Marsico SA; Saetta M
Eur Respir J; 2008 Jan; 31(1):62-9. PubMed ID: 17959643
[TBL] [Abstract][Full Text] [Related]
2. Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs.
Gaffey K; Reynolds S; Plumb J; Kaur M; Singh D
Eur Respir J; 2013 Jul; 42(1):28-41. PubMed ID: 23060629
[TBL] [Abstract][Full Text] [Related]
3. Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
Ito K; Ito M; Elliott WM; Cosio B; Caramori G; Kon OM; Barczyk A; Hayashi S; Adcock IM; Hogg JC; Barnes PJ
N Engl J Med; 2005 May; 352(19):1967-76. PubMed ID: 15888697
[TBL] [Abstract][Full Text] [Related]
4. The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway.
Liu Y; Xu S; Xiao F; Xiong Y; Wang X; Gao S; Yan W; Ning Q
Biochem Biophys Res Commun; 2010 May; 396(2):555-61. PubMed ID: 20438701
[TBL] [Abstract][Full Text] [Related]
5. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family.
Polverino F; Baraldo S; Bazzan E; Agostini S; Turato G; Lunardi F; Balestro E; Damin M; Papi A; Maestrelli P; Calabrese F; Saetta M
Am J Respir Crit Care Med; 2010 Oct; 182(8):1011-9. PubMed ID: 20581172
[TBL] [Abstract][Full Text] [Related]
6. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.
Calabrese F; Baraldo S; Bazzan E; Lunardi F; Rea F; Maestrelli P; Turato G; Lokar-Oliani K; Papi A; Zuin R; Sfriso P; Balestro E; Dinarello CA; Saetta M
Am J Respir Crit Care Med; 2008 Nov; 178(9):894-901. PubMed ID: 18703789
[TBL] [Abstract][Full Text] [Related]
7. p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation.
Medicherla S; Fitzgerald MF; Spicer D; Woodman P; Ma JY; Kapoun AM; Chakravarty S; Dugar S; Protter AA; Higgins LS
J Pharmacol Exp Ther; 2008 Mar; 324(3):921-9. PubMed ID: 18056868
[TBL] [Abstract][Full Text] [Related]
8. Age-induced augmentation of p38 MAPK phosphorylation in mouse lung.
Li Z; Li J; Bu X; Liu X; Tankersley CG; Wang C; Huang K
Exp Gerontol; 2011 Aug; 46(8):694-702. PubMed ID: 21570457
[TBL] [Abstract][Full Text] [Related]
9. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
[TBL] [Abstract][Full Text] [Related]
10. The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Patel NR; Cunoosamy DM; Fagerås M; Taib Z; Asimus S; Hegelund-Myrbäck T; Lundin S; Pardali K; Kurian N; Ersdal E; Kristensson C; Korsback K; Palmér R; Brown MN; Greenaway S; Siew L; Clarke GW; Rennard SI; Make BJ; Wise RA; Jansson P
Int J Chron Obstruct Pulmon Dis; 2018; 13():1009-1019. PubMed ID: 29628759
[TBL] [Abstract][Full Text] [Related]
11. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease.
Suzuki M; Betsuyaku T; Ito Y; Nagai K; Nasuhara Y; Kaga K; Kondo S; Nishimura M
Am J Respir Cell Mol Biol; 2008 Dec; 39(6):673-82. PubMed ID: 18566336
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression.
Baraldo S; Bazzan E; Zanin ME; Turato G; Garbisa S; Maestrelli P; Papi A; Miniati M; Fabbri LM; Zuin R; Saetta M
Chest; 2007 Dec; 132(6):1733-40. PubMed ID: 17646237
[TBL] [Abstract][Full Text] [Related]
13. p38 mitogen-activated protein kinase is not activated in the quadriceps of patients with stable chronic obstructive pulmonary disease.
Riddoch-Contreras J; George T; Natanek SA; Marsh GS; Hopkinson NS; Tal-Singer R; Kemp P; Polkey MI
COPD; 2012 Apr; 9(2):142-50. PubMed ID: 22409248
[TBL] [Abstract][Full Text] [Related]
14. Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium.
Vallese D; Ricciardolo FL; Gnemmi I; Casolari P; Brun P; Sorbello V; Capelli A; Cappello F; Cavallesco GN; Papi A; Chung KF; Balbi B; Adcock IM; Caramori G; Di Stefano A
Respiration; 2015; 89(4):329-42. PubMed ID: 25791156
[TBL] [Abstract][Full Text] [Related]
15. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].
Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN
Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637
[TBL] [Abstract][Full Text] [Related]
16. Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers.
Vernooy JH; Drummen NE; van Suylen RJ; Cloots RH; Möller GM; Bracke KR; Zuyderduyn S; Dentener MA; Brusselle GG; Hiemstra PS; Wouters EF
Thorax; 2009 Jan; 64(1):26-32. PubMed ID: 18835960
[TBL] [Abstract][Full Text] [Related]
17. Expression of the atypical chemokine receptor D6 in human alveolar macrophages in COPD.
Bazzan E; Saetta M; Turato G; Borroni EM; Cancellieri C; Baraldo S; Savino B; Calabrese F; Ballarin A; Balestro E; Mantovani A; Cosio MG; Bonecchi R; Locati M
Chest; 2013 Jan; 143(1):98-106. PubMed ID: 22797410
[TBL] [Abstract][Full Text] [Related]
18. Differential tissue expression and activation of p38 MAPK alpha, beta, gamma, and delta isoforms in rheumatoid arthritis.
Korb A; Tohidast-Akrad M; Cetin E; Axmann R; Smolen J; Schett G
Arthritis Rheum; 2006 Sep; 54(9):2745-56. PubMed ID: 16947383
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells.
Vintman L; Nielsen S; Berner A; Reich R; Davidson B
Cancer; 2005 Jun; 103(11):2427-33. PubMed ID: 15830375
[TBL] [Abstract][Full Text] [Related]
20. MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis.
Yoshida K; Kuwano K; Hagimoto N; Watanabe K; Matsuba T; Fujita M; Inoshima I; Hara N
J Pathol; 2002 Nov; 198(3):388-96. PubMed ID: 12375272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
